Pancreatic Alpha-Amylase

When elevated (>53 U/L):

Immediate actions:

• Discontinue all oral 17-alpha-alkylated AAS (Dianabol, Winstrol, Anavar, Anadrol, Superdrol)
• Assess GH and insulin doses — consider reducing or cycling off
• Order lipase as well — lipase is more sensitive and specific for pancreatitis
• Check triglycerides — hypertriglyceridemia >11.3 mmol/L can independently cause pancreatitis

If mildly elevated (53-100 U/L) without symptoms:

• Eliminate alcohol completely while on hepatotoxic compounds
• NAC (N-Acetyl Cysteine) -- 600mg 2x/day (hepatoprotective, reduces biliary stress)
• TUDCA -- 250-500mg/day (supports bile flow, reduces cholestasis risk — a pathway to secondary pancreatitis)
• Recheck in 2-4 weeks — if still elevated, imaging (abdominal ultrasound or CT) may be warranted

If significantly elevated (>100 U/L) or with symptoms (severe epigastric pain, nausea, vomiting):

• Seek medical attention immediately — acute pancreatitis can be life-threatening
• Stop all PEDs pending evaluation

Prevention:

• Baseline pancreatic amylase before starting oral AAS or GH/insulin protocols
• Recheck at week 4-6 of oral AAS use
• Limit oral AAS cycles to 4-6 weeks maximum
• Avoid alcohol during all oral AAS cycles
• Monitor triglycerides — keep below 2.3 mmol/L

References:

• Rosenfeld, G. A., & Chang, A. (2011). Cholestatic jaundice, acute kidney injury and acute pancreatitis secondary to methandrostenolone. Journal of Medical Case Reports, 5, 138. DOI: 10.1186/1752-1947-5-138
• Fathalla, B. M., Hamid, S. A., & Gaber, R. (2018). Acute pancreatitis secondary to trenbolone acetate. Clinical Toxicology, 57(1), 58-60. DOI: 10.1080/15563650.2018.1491983
• Krishnamoorthy, S., Bhadra, S., Engelen, M. P. K. J., & Cho, S. (2022). Drug-induced acute pancreatitis in a bodybuilder. Journal of Medical Case Reports, 16, 118. DOI: 10.1186/s13256-022-03329-3